Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders
- PMID: 30868422
- PMCID: PMC7212499
- DOI: 10.1007/s13365-019-00735-0
Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders
Abstract
HIV-associated neurocognitive disorders (HAND) continue to affect a large proportion of persons living with HIV despite effective viral suppression with combined antiretroviral therapy (cART). Importantly, milder versions of HAND have become more prevalent. The pathogenesis of HAND in the era of cART appears to be multifactorial with contributions from central nervous system (CNS) damage that occur prior to starting cART, chronic immune activation, cART neurotoxicity, and various age-related comorbidities (i.e., cardiovascular and cerebrovascular disease, diabetes, hyperlipidemia). Individuals with HIV may experience premature aging, which could also contribute to cognitive impairment. Likewise, degenerative disorders aside from HAND increase with age and there is evidence of shared pathology between HAND and other neurodegenerative diseases, such as Alzheimer's disease, which can occur with or without co-existing HAND. Given the aforementioned complex interactions associated with HIV, cognitive impairment, and aging, it is important to consider an age-appropriate differential diagnosis for HAND as the HIV-positive population continues to grow older. These factors make the accuracy and reliability of the diagnosis of mild forms of HAND in an aging population of HIV-infected individuals challenging. The complexity of current diagnosis of mild HAND also highlights the need to develop reliable biomarkers. Ultimately, the identification of a set of specific biomarkers will be required to achieve early and accurate diagnosis, which will be necessary assuming specific treatments for HAND are developed.
Keywords: HAND; HIV; aging; biomarkers; cognitive impairment.
Figures
Similar articles
-
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.J Neurovirol. 2019 Oct;25(5):710-721. doi: 10.1007/s13365-018-0706-5. Epub 2019 Jan 11. J Neurovirol. 2019. PMID: 30635846 Review.
-
The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.J Neurovirol. 2019 Oct;25(5):661-672. doi: 10.1007/s13365-018-0702-9. Epub 2019 Jan 22. J Neurovirol. 2019. PMID: 30671777 Free PMC article. Review.
-
Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4. J Neurovirol. 2019. PMID: 30610738 Free PMC article. Review.
-
Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.AIDS Patient Care STDS. 2018 Jan;32(1):1-8. doi: 10.1089/apc.2017.0202. AIDS Patient Care STDS. 2018. PMID: 29323557
-
Changing clinical phenotypes of HIV-associated neurocognitive disorders.J Neurovirol. 2018 Apr;24(2):141-145. doi: 10.1007/s13365-017-0556-6. Epub 2017 Jul 27. J Neurovirol. 2018. PMID: 28752495 Free PMC article. Review.
Cited by
-
HIV-Associated Neurocognitive Disorder (HAND): Obstacles to Early Neuropsychological Diagnosis.Int J Gen Med. 2022 Apr 15;15:4079-4090. doi: 10.2147/IJGM.S295859. eCollection 2022. Int J Gen Med. 2022. PMID: 35450033 Free PMC article. Review.
-
Extracellular vesicles regulate gap junction-mediated intercellular communication and HIV-1 infection of human neural progenitor cells.Neurobiol Dis. 2021 Jul;155:105388. doi: 10.1016/j.nbd.2021.105388. Epub 2021 May 5. Neurobiol Dis. 2021. PMID: 33962010 Free PMC article.
-
Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders.Sci Rep. 2023 Feb 25;13(1):3276. doi: 10.1038/s41598-022-27276-7. Sci Rep. 2023. PMID: 36841839 Free PMC article.
-
Nef-induced CCL2 Expression Contributes to HIV/SIV Brain Invasion and Neuronal Dysfunction.Front Immunol. 2019 Oct 15;10:2447. doi: 10.3389/fimmu.2019.02447. eCollection 2019. Front Immunol. 2019. PMID: 31681324 Free PMC article. Review.
-
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice.Pharmaceuticals (Basel). 2024 Jan 23;17(2):149. doi: 10.3390/ph17020149. Pharmaceuticals (Basel). 2024. PMID: 38399364 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical